Logo image of VIV.PA

VIVENDI SE (VIV.PA) Stock Fundamental Analysis

Europe - EPA:VIV - FR0000127771 - Common Stock

2.987 EUR
0 (-0.17%)
Last: 9/19/2025, 5:29:50 PM
Fundamental Rating

2

VIV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 46 industry peers in the Entertainment industry. The financial health of VIV is average, but there are quite some concerns on its profitability. VIV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

VIV had negative earnings in the past year.
VIV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VIV reported negative net income in multiple years.
Each year in the past 5 years VIV had a positive operating cash flow.
VIV.PA Yearly Net Income VS EBIT VS OCF VS FCFVIV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

1.2 Ratios

Looking at the Return On Assets, with a value of -81.94%, VIV is doing worse than 89.13% of the companies in the same industry.
VIV's Return On Equity of -124.64% is on the low side compared to the rest of the industry. VIV is outperformed by 73.91% of its industry peers.
Industry RankSector Rank
ROA -81.94%
ROE -124.64%
ROIC N/A
ROA(3y)-25.96%
ROA(5y)-0.02%
ROE(3y)-44.73%
ROE(5y)1.01%
ROIC(3y)N/A
ROIC(5y)N/A
VIV.PA Yearly ROA, ROE, ROICVIV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

1.3 Margins

VIV has a worse Gross Margin (28.96%) than 78.26% of its industry peers.
VIV's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for VIV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y-8.18%
VIV.PA Yearly Profit, Operating, Gross MarginsVIV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

4

2. Health

2.1 Basic Checks

VIV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VIV has less shares outstanding
Compared to 5 years ago, VIV has less shares outstanding
The debt/assets ratio for VIV is higher compared to a year ago.
VIV.PA Yearly Shares OutstandingVIV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
VIV.PA Yearly Total Debt VS Total AssetsVIV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

VIV has an Altman-Z score of 1.34. This is a bad value and indicates that VIV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.34, VIV is in line with its industry, outperforming 54.35% of the companies in the same industry.
The Debt to FCF ratio of VIV is 1.38, which is an excellent value as it means it would take VIV, only 1.38 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of VIV (1.38) is better than 82.61% of its industry peers.
A Debt/Equity ratio of 0.39 indicates that VIV is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.39, VIV is doing good in the industry, outperforming 60.87% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 1.38
Altman-Z 1.34
ROIC/WACCN/A
WACC5.99%
VIV.PA Yearly LT Debt VS Equity VS FCFVIV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

VIV has a Current Ratio of 0.51. This is a bad value and indicates that VIV is not financially healthy enough and could expect problems in meeting its short term obligations.
VIV has a Current ratio of 0.51. This is in the lower half of the industry: VIV underperforms 78.26% of its industry peers.
A Quick Ratio of 0.51 indicates that VIV may have some problems paying its short term obligations.
VIV's Quick ratio of 0.51 is on the low side compared to the rest of the industry. VIV is outperformed by 76.09% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51
VIV.PA Yearly Current Assets VS Current LiabilitesVIV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

0

3. Growth

3.1 Past

VIV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1628.21%.
VIV shows a decrease in Revenue. In the last year, the revenue decreased by -4.81%.
The Revenue for VIV have been decreasing by -54.89% on average. This is quite bad
EPS 1Y (TTM)-1628.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.64%
Revenue 1Y (TTM)-4.81%
Revenue growth 3Y-67.58%
Revenue growth 5Y-54.89%
Sales Q2Q%-98.4%

3.2 Future

VIV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.57% yearly.
VIV is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -66.29% yearly.
EPS Next Y-61.11%
EPS Next 2Y-9.95%
EPS Next 3Y2.57%
EPS Next 5YN/A
Revenue Next Year-96.38%
Revenue Next 2Y-80.65%
Revenue Next 3Y-66.29%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
VIV.PA Yearly Revenue VS EstimatesVIV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
VIV.PA Yearly EPS VS EstimatesVIV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

VIV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 31.17, the valuation of VIV can be described as expensive.
VIV's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. VIV is cheaper than 65.22% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of VIV to the average of the S&P500 Index (22.88), we can say VIV is valued slightly more expensively.
Industry RankSector Rank
PE N/A
Fwd PE 31.17
VIV.PA Price Earnings VS Forward Price EarningsVIV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of VIV indicates a rather cheap valuation: VIV is cheaper than 95.65% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.15
EV/EBITDA N/A
VIV.PA Per share dataVIV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.95%
EPS Next 3Y2.57%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.31%, VIV has a reasonable but not impressive dividend return.
VIV's Dividend Yield is rather good when compared to the industry average which is at 1.96. VIV pays more dividend than 80.43% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, VIV's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.31%

5.2 History

The dividend of VIV decreases each year by -13.55%.
Dividend Growth(5Y)-13.55%
Div Incr Years0
Div Non Decr Years2
VIV.PA Yearly Dividends per shareVIV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

The earnings of VIV are negative and hence is the payout ratio. VIV will probably not be able to sustain this dividend level.
DP-0.67%
EPS Next 2Y-9.95%
EPS Next 3Y2.57%
VIV.PA Yearly Income VS Free CF VS DividendVIV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

VIVENDI SE

EPA:VIV (9/19/2025, 5:29:50 PM)

2.987

0 (-0.17%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)07-31 2025-07-31
Earnings (Next)10-20 2025-10-20
Inst Owners25.97%
Inst Owner ChangeN/A
Ins Owners30.04%
Ins Owner ChangeN/A
Market Cap3.08B
Analysts75.71
Price Target3.7 (23.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.31%
Yearly Dividend0.25
Dividend Growth(5Y)-13.55%
DP-0.67%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.27%
PT rev (3m)20.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-39.64%
EPS NY rev (3m)-39.64%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.82%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 31.17
P/S 10.36
P/FCF 2.15
P/OCF 2.64
P/B 0.64
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)-5.96
EYN/A
EPS(NY)0.1
Fwd EY3.21%
FCF(TTM)1.39
FCFY46.55%
OCF(TTM)1.13
OCFY37.87%
SpS0.29
BVpS4.68
TBVpS4.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -81.94%
ROE -124.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.96%
FCFM 482.16%
ROA(3y)-25.96%
ROA(5y)-0.02%
ROE(3y)-44.73%
ROE(5y)1.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y-8.18%
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 1.38
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 89.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z 1.34
F-Score4
WACC5.99%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)44.94%
Cap/Sales(5y)29.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1628.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.64%
EPS Next Y-61.11%
EPS Next 2Y-9.95%
EPS Next 3Y2.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.81%
Revenue growth 3Y-67.58%
Revenue growth 5Y-54.89%
Sales Q2Q%-98.4%
Revenue Next Year-96.38%
Revenue Next 2Y-80.65%
Revenue Next 3Y-66.29%
Revenue Next 5YN/A
EBIT growth 1Y-58.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year70.6%
EBIT Next 3Y31.38%
EBIT Next 5YN/A
FCF growth 1Y1178.57%
FCF growth 3Y16%
FCF growth 5Y16.53%
OCF growth 1Y133%
OCF growth 3Y3.97%
OCF growth 5Y7.73%